1. A Randomized Controlled Study to Determine the Efficacy of Garlic Compounds in Patients With Hematological Malignancies at Risk for Chemotherapy-Related Febrile Neutropenia. (September 2015) Authors: Gatt, Moshe E.; Strahilevitz, Jacob; Sharon, Nir; Lavie, David; Goldschmidt, Neta; Kalish, Yossef; Gural, Alexander; Paltiel, Ora B. Journal: Integrative cancer therapies Issue: Volume 14:Number 5(2015:Sep.) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abstracts from the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19–20 September 2014. Issue 5 (May 2015) Authors: Zwarthoed, Cholette; Ouvier, Matthieu John; Borra, Anna; Bergesio, Fabrizio; Chauvie, Stephane; Biggi, Alberto; Hutchings, Martin; El-Galaly, Tarek; Gallamini, Andrea; Simon, Zsófia; Miltényi, Zsófia; Magyari, Ferenc; Barna, Sándor; Kenyeres, Anna; Jóna, Ádám; Illés, Árpád; Dann, Eldad J.; Bar-Sh... Journal: Leukemia & lymphoma Issue: Volume 56:Issue 5(2015:May) Page Start: 1233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bortezomib‐induced peripheral neuropathy is related to altered levels of brain‐derived neurotrophic factor in the peripheral blood of patients with multiple myeloma. (25th October 2013) Authors: Azoulay, David; Lavie, David; Horowitz, Netanel; Suriu, Celia; Gatt, Moshe E.; Akria, Luiza; Perlman, Riki; Braester, Andrei; Ben‐Yehuda, Dina Journal: British journal of haematology Issue: Volume 164:Number 3(2014:Feb.) Page Start: 454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Daratumumab resistance is frequent in advanced‐stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis. (25th March 2018) Authors: Pick, Marjorie; Vainstein, Vladimir; Goldschmidt, Neta; Lavie, David; Libster, Diana; Gural, Alexander; Grisariu, Sigal; Avni, Batia; Ben Yehuda, Dina; Gatt, Moshe E. Journal: European journal of haematology Issue: Volume 100:Number 5(2018) Page Start: 494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Duodenal amyloid A depositions in a patient with refractory Hodgkin's lymphoma: an old complication in the modern treatment era. (2nd October 2018) Authors: Shaulov, Adir; Prus, Diana; Lavie, David; Elias, Shlomo Journal: Amyloid Issue: Volume 25:Number 4(2018) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients. (7th June 2017) Authors: Dann, Eldad J.; Bairey, Osnat; Bar‐Shalom, Rachel; Mashiach, Tanya; Barzilai, Elinor; Kornberg, Abraham; Akria, Luiza; Tadmor, Tamar; Filanovsky, Kalman; Abadi, Uri; Kagna, Olga; Ruchlemer, Rosa; Abdah‐Bortnyak, Roxolyana; Goldschmidt, Neta; Epelbaum, Ron; Horowitz, Netanel A.; Lavie, David; Ben‐... Journal: British journal of haematology Issue: Volume 178:Number 5(2017) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial. Issue 2 (February 2018) Authors: Harrison, Claire N; Vannucchi, Alessandro M; Platzbecker, Uwe; Cervantes, Francisco; Gupta, Vikas; Lavie, David; Passamonti, Francesco; Winton, Elliott F; Dong, Hua; Kawashima, Jun; Maltzman, Julia D; Kiladjian, Jean-Jacques; Verstovsek, Srdan Journal: Lancet Issue: Volume 5:Issue 2(2018) Page Start: e73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Issue 10373 (28th January 2023) Authors: Verstovsek, Srdan; Gerds, Aaron T; Vannucchi, Alessandro M; Al-Ali, Haifa Kathrin; Lavie, David; Kuykendall, Andrew T; Grosicki, Sebastian; Iurlo, Alessandra; Goh, Yeow Tee; Lazaroiu, Mihaela C; Egyed, Miklos; Fox, Maria Laura; McLornan, Donal; Perkins, Andrew; Yoon, Sung-Soo; Gupta, Vikas; Kilad... Journal: Lancet Issue: Volume 401:Issue 10373(2023) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Parameters associated with sperm quality prior to chemotherapy in lymphoma patients. (19th August 2020) Authors: Karavani, Gilad; Feigin, Nissan; Tachover, Tzipora; Bdolah‐Abram, Tali; Lavie, David; Ben‐Yehuda, Dina; Ben‐Meir, Assaf Journal: Andrologia Issue: Volume 52:Number 10(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pityriasis rubra pilaris induced by PD‐1 inhibitor nivolumab. (12th April 2021) Authors: Goldberger, Tal; Armoni, Gil; Lavie, David; Merims, Sharon; Maly, Alexander; Shreberk‐Hassidim, Rony Journal: International journal of dermatology Issue: Volume 60:Number 8(2021) Page Start: 1038 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗